StockData
INBSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30

INTELLIGENT BIO SOLUTIONS INC.

Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K/A on Oct 21, 2026
$1.53+0.03 (+2.00%)

Close on Oct 19, 2026

Market cap
$3.83M
P/E (TTM)
–
Dividend yield
–

INTELLIGENT BIO SOLUTIONS INC. revenue by segment

By business segment

By product or service

RevenueTTM Q4 26TTM Q3 26TTM Q2 26TTM Q1 26TTM Q4 25TTM Q3 25TTM Q2 25TTM Q1 25TTM Q4 24TTM Q3 24TTM Q2 24TTM Q1 24% of revenueYoY
Sales of Goods - Cartidges [Member]$2.49M$2.34M$2.08M$1.95M$1.76M$1.67M$1.68M$1.62M$1.55M$1.42M$1.22M$1.10M59.0%+41.1%
Sales of Goods - Readers [Member]$902.26K$864.20K$890.60K$764.86K$711.74K$707.22K$768.78K$933.88K$938.90K$850.36K$757.37K$574.67K21.4%+26.8%
Other sales - accessories [Member]$827.35K–––$578.64K–––––––19.6%+43.0%
Other Sales [Member]–––$573.24K$578.64K$560.88K$587.41K$636.23K$623.48K$559.59K$482.03K$373.94K––
IFPG [Member]–––––$2.90M$2.96M$3.14M$3.11M$2.95M$2.57M$2.10M––

By region

RevenueTTM Q4 26TTM Q3 26TTM Q2 26TTM Q1 26TTM Q4 25TTM Q3 25TTM Q2 25TTM Q1 25TTM Q4 24TTM Q3 24TTM Q2 24TTM Q1 24% of revenueYoY
United Kingdom$4.15M$3.75M$3.41M$3.11M$2.87M$2.76M$2.86M$2.96M$2.89M$2.59M$2.17M$1.82M98.5%+44.8%
Asia Pacific [Member]$12.47K$24.24K$25.85K$30.27K$29.17K–––––––0.3%-57.3%
Other Country [Member]–$132.38K$131.65K$132.15K$132.70K$111.50K$115.54K$166.14K$162.22K$192.21K$262.86K$222.36K––
Australia–––––$22.11K$25.61K$36.45K$43.96K–––––

From the segment and revenue-disaggregation notes of Intelligent Bio Solutions's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.